ABBV-105
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for ABBV-105, covering 2021-05-03 to 2021-09-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study in Rheumatoid Arthritis Patients Who Have Completed a Preceding Study With ABBV-105 Given Alone or in Combination With Upadacitinib [Phase 2]